Document:

Exhibit
4.5

 

NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

WARRANT
TO PURCHASE ORDINARY SHARES

 

Jeffs’
Brands Ltd

 

	Warrant Shares: 30,048	 	Initial
                                            Exercise Date: August 30, 2022

 

THIS
WARRANT TO PURCHASE ORDINARY SHARES (the “Warrant”) certifies that, for value received, ________________ or his assigns
(the “Holder”) is entitled, upon the terms and the limitations on exercise and the conditions hereinafter set forth,
at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on
August 30, 2025 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Jeffs’ Brands
Ltd, an Israeli company (the “Company”), up to 30,048 ordinary shares, no par value of the Company (the “Ordinary
Shares”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Ordinary
Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

 

Section
1. Definitions. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated
in this Section 1:

 

“Board
of Directors” means the board of directors of the Company.

 

“Business
Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed
to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential
employee” or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental
authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York
generally are open for use by customers on such day.

 

“Commission”
means the United States Securities and Exchange Commission.

 

“Ordinary
Shares” means ordinary shares, no par value, of the Company, and any other class of securities into which such securities may
hereafter be reclassified or changed.

 

“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Trading
Day” means a day on which the Ordinary Shares are traded on a Trading Market.

 

“Trading
Market” means any of the following markets or exchanges on which the Ordinary Shares are listed or quoted for trading on the
date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York
Stock Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).

 

“Transfer
Agent” means VStock Transfer, LLC, the current transfer agent of the Ordinary Shares, with a mailing address of 18 Lafayette
Place, Woodmere, NY 11598, and a facsimile number of 646-536-3179, and any successor transfer agent of the Company.

 

     

     

    

 

Section
2. Exercise.

 

a)
Exercise of Warrant.  Subject to the provisions of Section 2(e) herein, exercise of the purchase rights represented by this Warrant
may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date, by
delivery to the Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form
annexed hereto as Annex A (the “Notice of Exercise”), and, unless the cashless exercise procedure specified in Section
2(c) below is specified in the applicable Notice of Exercise, delivery of the aggregate Exercise Price of the Warrant Shares specified
in the applicable Notice of Exercise as specified in this Section 2(a). Within the earlier of (i) two (2) Trading Days and (ii) the number
of Trading Days comprising the Standard Settlement Period following the date of exercise as aforesaid, the Holder shall deliver the aggregate
Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer of immediately available funds
or cashier’s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified
in the applicable Notice of Exercise. As used herein, “Standard Settlement Period” means the standard settlement period,
expressed in a number of Trading Days, on the Company’s primary Trading Market with respect to the Ordinary Shares as in effect
on the date of delivery of the Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee
(or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant
Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the
Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company.
Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall
have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number
of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the
date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such
notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this
paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder
at any given time may be less than the amount stated on the face hereof. 

  

b) Exercise
Price. The exercise price per Ordinary Share under this Warrant shall be $4.04 (the “Initial Exercise Price”),
subject to adjustment hereunder (as in effect from time to time, the “Exercise Price”).

 

c) Cashless
Exercise. This Warrant may also be exercised, in whole or in part, by means of a “cashless exercise” in which the Holder
shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

	 	(A) =	as
    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
    Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined
    in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder,
    either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of
    the Ordinary Shares on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder’s execution
    of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular trading hours” on a Trading
    Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of “regular trading hours”
    on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date
    of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof
    after the close of “regular trading hours” on such Trading Day;

 

	 	(B) =	the Exercise
    Price of this Warrant, as adjusted hereunder; and

 

	 	(X) =	the number
    of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise
    were by means of a cash exercise rather than a cashless exercise.

 

    2

     

    

 

If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant
Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this
Section 2(c).

  

d) Mechanics
of Exercise.

 

i. Delivery
of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust
Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such
system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the
Warrant Shares by Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner of sale limitations
pursuant to Rule 144, and otherwise by physical delivery of a certificate, registered in the Company’s share register in the name
of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address
specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to
the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii)
the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such
date, the “Warrant Share Delivery Date”). Upon delivery of the Notice of Exercise, the Holder shall be deemed for
all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised,
irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the
case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising
the Standard Settlement Period following delivery of the Notice of Exercise.

  

ii. Delivery
of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.

   

iii. No
Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.

 

iv. Charges,
Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto as Annex B duly executed by the Holder and the Company may require,
as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay
all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another
established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.

 

v. Closing
of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.

  

Section
3. Certain Adjustments. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend
or otherwise makes a distribution or distributions on its Ordinary Shares or any other equity or equity equivalent securities payable
in Ordinary Shares (which, for avoidance of doubt, shall not include any Ordinary Shares issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding Ordinary Shares into a larger number of shares, (iii) combines (including by way of reverse stock
split) outstanding Ordinary Shares into a smaller number of shares, or (iv) issues by reclassification of Ordinary Shares any shares
of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall
be the number of Ordinary Shares and such other capital stock of the Company (excluding treasury shares, if any) outstanding immediately
before such event and of which the denominator shall be the number of Ordinary Shares and such other capital stock of the Company (excluding
treasury shares, if any) outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall
be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant
to this Section 3(a) shall become effective immediately after the record date for the determination of shareholders entitled to receive
such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination
or re-classification.

 

    3

     

    

 

Section
4.  Transfer of Warrant.

 

a) Transferability.
This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of
this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay
any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute
and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.

 

b) New
Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and
shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

c)
Representation by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempt from registration under the Securities Act.

 

Section
5.  Miscellaneous.

 

a) No
Rights as Stockholder until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a “cashless exercise” pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, including if the Company is for any
reason unable to issue and deliver Warrant Shares upon exercise of this Warrant as required pursuant to the terms hereof, in no event
shall the Company be required to net cash settle an exercise of this Warrant or cash settle in any other form.

  

b) Loss,
Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (including the posting of any bond), and upon surrender
and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

 

c) Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.

 

d) Authorized
Shares. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued
Ordinary Shares a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights
under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who
are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company
will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without
violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Ordinary Shares may be listed.
The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant
will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be
duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect
of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

    4

     

    

  

Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.

  

e) Governing
Law. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York,
Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is
not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant,
the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys’
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. Notwithstanding
the foregoing, nothing in this paragraph shall limit or restrict the federal district court in which a Holder may bring a claim under
the U.S. federal securities laws.

 

f) Restrictions.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will have restrictions
upon resale imposed by state and federal securities laws.

 

g) Non-waiver
and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. No provision of this Warrant shall be construed
as a waiver by the Holder of any rights which the Holder may have under the U.S. federal securities laws and the rules and regulations
of the Commission thereunder. Without limiting any other provision of this Warrant, if the Company willfully and knowingly fails to comply
with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts
as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those
of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights,
powers or remedies hereunder.

 

h) Notices.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any
Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service,
addressed to the Company, at 3 Hanechoshet Street, Tel Aviv, Israel 6971068, Attention: Chief Executive Officer, email address:
victor@jeffsbrands.com, or such other email address or address as the Company may specify for such purposes by notice to the Holders.
Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally,
by e-mail, or sent by a nationally recognized overnight courier service addressed to the Holder,_____________. Any notice or other communication
or deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication
is delivered via e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the
next Trading Day after the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth
in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second
Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt
by the party to whom such notice is required to be given. To the extent that any notice provided hereunder constitutes, or contains,
material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the
Commission pursuant to a Report on Form 6-K.

 

i) Limitation
of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Ordinary Shares or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of
the Company.

 

    5

     

    

  

j) Remedies.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.

 

k) Successors
and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.

 

l) Amendment.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder, on the other hand.

 

m) Severability.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

 

n) Headings.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.

 

 

********************

 

(Signature
Page Follows)

 

    6

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.

 

	 	Jeffs’
    Brands Ltd
	 	 
	 	By:	/s/
    Viki Hakmon
	 	 	Name: 	Viki Hakmon
	 	 	Title:	Chief Executive Officer
	 	 
	 	By: 	/s/
    Ronen Zalayet
	 	 	Name: 	Ronen Zalayet
	 	 	Title:	Chief Financial Officer

 

    7

     

    

 

ANNEX
A

 

NOTICE
OF EXERCISE

 

To:
Jeffs’ Brands Ltd

 

(1)  
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

(2)  
Payment shall take the form of (check applicable box):

☐ in lawful money of the United States.

(3)  
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

_______________________________

 

 

The
Warrant Shares shall be delivered to the following DWAC Account Number:

 

_______________________________

 

_______________________________

 

_______________________________

 

(4)
Accredited Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.

 

[SIGNATURE
OF HOLDER]

 

Name
of Investing Entity: ___________________________________________________________________________

Signature
of Authorized Signatory of Investing Entity: _____________________________________________________

Name
of Authorized Signatory: _______________________________________________________________________

Title
of Authorized Signatory: ________________________________________________________________________

Date:
___________________________________________________________________________________________

 

    A-1

     

    

 

ANNEX
B

 

ASSIGNMENT
FORM

 

(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

 

FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

	Name:	_____________________________________________
	 	(Please
    Print)
	Address:	_____________________________________________
	 

    Phone
    Number:

    Email
    Address:
	(Please
    Print)

    ______________________________________

    ______________________________________

	Dated:
    _______________ __, ______	 
	Holder’s
    Signature:______________________________ 	 
	Holder’s
    Address:_______________________________	 

 

 

    B-1

     

    

 

SCHEDULE
TO EXHIBIT 4.5

 

	Warrant
    Holder	 	Address
    for Notice
	M.R.M
    Merhavit Holdings and Management LTD.	 	31
    Sokolov street, Ramat-Gan 5256418,

    Attention: Moti Menashe, E-mail address: moti@upwing.co.il
	Tamarid
    LTD. 	 	2
    Koyfmann street, Tel Aviv, Israel 6801294, Attention: Mali Sagi, E-mail address: mali@avco-chem.co.ilExhibit 10.1

 

Representative Form of Indemnification Agreement

 

This Indemnification Agreement (this “Agreement”)
is made as of November 20, 2022, by and between Jeffs’ Brands Ltd, a company organized and existing under the laws of Israel (the
“Company”) and Ronen Zalayet (“Indemnitee”).

 

WHEREAS, the Company desires to attract and retain
qualified directors and officers and to provide them with protection against liability and expenses incurred while acting in that capacity;
and

 

WHEREAS, Indemnitee is director or officer of
the Company; and

 

WHEREAS, in order to induce Indemnitee to serve
as a director or officer of the Company, the Company agrees to indemnify Indemnitee upon certain occurrences, pursuant to the terms and
subject to the conditions of this Agreement.

 

Now, therefore, the parties agree as follows:

 

		1.	Indemnity. The Company hereby agrees, subject to the limitations set forth in this Agreement and
to applicable law:

 

To indemnify Indemnitee to the maximum extent
permitted by applicable law against any liability or expense in respect of any acts or omissions of Indemnitee in his capacity as a director
or officer of the Company, as follows:

 

(i) a financial obligation imposed on Indemnitee
in favor of another person by a court judgment, including a compromise judgment or an arbitrator’s award approved by court;

 

(ii) reasonable litigation expenses, including
attorneys’ fees, expended by Indemnitee or charged to him by a court, in a proceeding instituted against him by the Company or on its
behalf or by another person, or in a criminal charge from which he was acquitted or in any criminal proceeding of a crime which does not
require proof of mens rea (criminal intent) in which the Indemnitee is convicted, or due to an investigation or a proceeding conducted
against him by an authority authorized to conduct an investigation or a proceeding, pursuant to which no indictment was filed against
him and no monetary liability was imposed on him as an alternative to a criminal proceeding, or due to an investigation or a proceeding
conducted against him by an authority authorized to conduct an investigation or a proceeding, pursuant to which no indictment was filed
against him but a monetary liability was imposed on him as an alternative to a criminal proceeding, for a crime which does not require
a finding of mens rea (criminal intent) (collectively referred to hereinafter as a “Claim”);

 

(iii) a payment which Indemnitee is obligated
to make to an injured party as set forth in Section 52(54)(a)(1)(a) of the Israeli Securities Law, 1968, as amended (the “Securities
Law”), if applicable, and expenses that Indemnitee incurs in connection with a proceeding under Chapters H’3, H’4
or I’1 of the Securities Law, if applicable, including reasonable legal expenses, which term includes attorney fees; and

 

    1

     

    

 

(iv) any other obligation or expense in respect
of which it is permitted or will be permitted under the Companies Law, 5759-1999, to indemnify an officer or director, subject to and
in accordance with all applicable law.

 

The above indemnification will also apply to any
action taken by the Indemnitee in his capacity as a director and/or officer of any other company controlled, directly or indirectly, by
the Company (a “Subsidiary”) or in his capacity as a director, officer or observer at board of directors’ meetings,
of a company not controlled by the Company but where his appointment as a director, officer or observer results from the Company’s
holdings in such company (“Affiliate”).

 

		2.	General Limitations on Indemnity. If, when and to the extent that a final judicial determination
is made, as to which all rights of appeal therefrom have been exhausted or lapsed, the Indemnitee would not be permitted to be so indemnified
as provided under this Agreement, the Company shall be entitled to be reimbursed by Indemnitee (who hereby agrees to reimburse the Company)
for all such amounts theretofore paid. Indemnitee’s obligation to reimburse the Company for any advance expenses or other sums paid
hereunder shall be unsecured and no interest shall be charged thereon.

 

		3.	Limitations on Indemnity.

 

3.1. The
Company undertakes to indemnify Indemnitee, with respect to Section 1(i) above, and in accordance with the terms of this Agreement up
to a total amount of US$5,000,000 (Five Million United States Dollars) in the aggregate, under the circumstances of indemnification of
Indemnitee as set forth in this Agreement.

 

3.2. Indemnitee
shall not be entitled to indemnification under Section 1, for financial obligations imposed arising from any of the following: (i) a breach
of the duty of fiduciary by Indemnitee, except, to the extent permitted by law, for a breach of the duty of fiduciary by the Indemnitee
to the Company, a Subsidiary or an Affiliate while acting in good faith and having reasonable cause to assume that such act would not
prejudice the interests of the Company, Subsidiary or Affiliate, as applicable; or (ii) a violation of the Indemnitee’s duty of
care towards the Company, which was committed intentionally or recklessly, except if it was done in negligence only; or (iii) an act committed
with the intention to realize a personal unlawful profit; or (iv) a fine or monetary penalty imposed on Indemnitee (excluding a fine or
monetary penalty imposed pursuant to the conviction of a crime which requires proof of mens rea (criminal intent)); or (v) a counterclaim
made by the Company or in its name in connection with a claim against the Company filed by Indemnitee, other than (a) by way of defense
or by way of third party notice in connection with claim brought against the Indemnitee, or (b) in specific cases in which the Company’s
Board of Directors has approved the initiation or bringing of such suit by Indemnitee, which approval shall not be unreasonably withheld.

 

3.3. The
indemnification amount actually paid shall be limited to those amounts not covered by the Company’s directors and officers insurance
policy (the “D&O Policy”), such that Indemnitee will not be entitled to payment from the Company for amounts which
Indemnitee has actually obtained under the D&O Policy.

 

    2

     

    

 

3.4. Subject
to the provisions of this Section 3, the indemnification hereunder will, in each case, cover all sums of money that the Indemnitee will
be obligated to pay, in those circumstances for which indemnification is permitted under the law.

 

3.5. The
Company will be entitled to reimbursement of amounts collected from a third party in connection with liabilities indemnified hereunder.
Such reimbursement shall not exceed the amount the Company has paid to the Indemnitee.

 

		4.	Limitation of Categories of Claims. The indemnification pursuant to Section 1(i) above, shall only
relate to liabilities arising in connection with acts or omissions of Indemnitee in respect of the following events and circumstances
which are deemed by the Company’s Board of Directors to be foreseeable at the date hereof:

 

4.1. The
offering of securities by the Company and/or by a shareholder thereof to the public and/or to private investors or the offer by the Company
to purchase securities from the public and/or from private investors or other holders pursuant to a prospectus, agreements, notices, reports,
tenders and/or other proceedings;

 

4.2. Occurrences
in connection with investments in or by the Company and/or Subsidiary and/or Affiliate in other corporations whether before and/or after
the investment is made, entering into the transaction, the execution, development and monitoring thereof, including actions taken by the
Indemnitee in the name of the Company and/or Subsidiary and/or Affiliate as a director, officer, employee and/or board observer of the
corporation which is the subject of the transaction and the like;

 

4.3. The
sale, purchase and holding of negotiable securities or other investments for or in the name of the Company and/or Subsidiary and/or Affiliate;

 

4.4. Actions
in connection with the merger of the Company and/or any Subsidiary and/or any Affiliate with or into another entity;

 

4.5. Actions
in connection with the sale of the operations, assets and/or business, or part thereof, of the Company and/or Subsidiary and/or Affiliate;

 

4.6. Without
derogating from the generality of the above, actions in connection with the purchase or sale of companies, legal entities or assets, licensing
or acquisition of rights in products, assets or technologies of other persons or legal entities, and the sale, licensing or grant of license
in the same to other persons or legal entities, and the division or consolidation thereof;

 

4.7. Actions
taken in connection with labor relations and/or employment matters (including employment-related benefits) in the Company and/or Subsidiary
and/or Affiliate and trade relations of the Company and/or Subsidiary and/or Affiliate, including with employees, independent contractors,
customers, suppliers and various service providers;

 

    3

     

    

 

4.8. Actions
in connection with the developing, testing and manufacturing of products (including a third party’s products, solutions and technologies)
by the Company and/or Subsidiary and/or Affiliate or in connection with the distribution, sale, license or use of such products, solutions
or technologies, and management of projects whether of the Company and/or Subsidiary and/or affiliate and/or any third party;

 

4.9. Actions
relating to the promotion, offering and/or support of the products, solutions and technologies in the fields of operation of the Company,
any of its Subsidiaries or Affiliates as shall exist from time to time;

 

4.10. Actions
taken in connection with the intellectual property of the Company and/or Subsidiary and/or Affiliate and its protection, including the
registration or assertion of rights to intellectual property and the defense of claims related to intellectual property or any claim or
demand made for actual or alleged infringement, misappropriation, or misuse of any third party’s intellectual property rights by the Company,
its Subsidiaries or Affiliates, including without limitation confidential information, patents, copyrights, design rights, service marks,
trade secrets, copyrights, and misappropriation of ideas by the Company, its Subsidiaries or Affiliates;

 

4.11. Actions
taken pursuant to or in accordance with the policies and procedures of the Company and/or Subsidiary and/or Affiliate, that have been
decided upon, whether such policies and procedures are published or not, and actions relating to the operations and management of the
Company and/or of any Subsidiaries and/or Affiliates;

 

4.12. Occurrences
resulting from the Company’s and/or Subsidiary’s and/or Affiliate’s status as a public company, and/or from the fact
that the Company’s securities were offered to the public and/or are traded on a stock exchange, whether in the U.S. or elsewhere;

 

4.13. Any
claim or demand made by any lenders or other creditors or for monies borrowed by, or other indebtedness of, the Company and\or Subsidiary
and/or any Affiliate;

 

4.14. Any
claim or demand made by any third party suffering any personal injury or damage to business or personal property through any act or omission
attributed to the Company or its Subsidiaries or its Affiliates, or their respective employees, agents or other persons acting or allegedly
acting on their behalf;

 

4.15. Any
claim or demand made by suppliers, contractors or other third parties transacting any form of business with the Company in the ordinary
course of their respective businesses, relating to the negotiations or performance of such transactions, representations or inducements
provided in connection thereto or otherwise;

 

4.16. Any
claim or demand made in connection with any transaction not in the ordinary course of business of either the Company or the party making
such claim (including any transaction with directors or officers of the Company or any controlling shareholder of the Company);

 

4.17. Any
claim or demand made directly or indirectly in connection with complete or partial failure, by the Company and\or Subsidiary and/or Affiliate,
or their respective directors, officers and employees, to pay, report, keep applicable records or otherwise, any federal, state, municipal
or foreign taxes or other mandatory payments of any nature whatsoever, including, without limitation, income, sales, use, transfer, excise,
value added, registration, severance, stamp, occupation, customs, duties, real property, personal property, capital stock, social security,
unemployment, disability, payroll or employee withholding or other withholding, including any interest, penalty or addition thereto, whether
disputed or not;

 

    4

     

    

 

4.18. Any
actions or decisions relating to insurance matters and/or risk management of the Company;

 

4.19. The
filing of a report and/or announcement required by the Companies Law and/or any securities law which is applicable or may be applicable
to the Company from time to time, including the U.S. Securities Laws, including the regulations pertaining to these laws, the Israeli
Securities Law - 1968, and/or according to rules and/or regulations adopted by the stock market LLC or any other stock exchange and/or
securities market and/or any law of any other country pertaining to these issues and/or the failure to file such a report and/or announcement,
and/or actions relating to tender offers of the Company, including actions relating to delivery of opinions in relation thereto;

 

4.20. Any
decision regarding a distribution, as defined in the Companies Law, including a distribution pursuant to a court order, and/or repurchase
of shares or returns of capital or loans of the Company;

 

4.21. Any
actions in connection with the change in the Company’s structure and/or a reorganization of the Company, including any arrangement between
the Company and its shareholders and/or creditors according to the Companies Law, and/or any decision relating to these issues including,
but not limited to, a change in the Company’s capital, the establishment of subsidiaries and/or their liquidation or sale, and/or all
allotments or distributions;

 

4.22. Approval
of corporate actions, including the approval of acts of the Company’s management, its guidance and its supervision;

 

4.23. Any
claim or demand made in connection with any expression of opinion or saying made in good faith during the course of performance of duties
and in connection with the performance of duties, including during meetings of the board of directors or committees of the Company;

 

4.24. Any
administrative, regulatory or judicial actions, orders, decrees, suits, demands, demand letters, directives, claims, liens, investigations,
proceedings or notices of noncompliance or violation by any governmental entity (in Israel or abroad), including the Office of the Chief
Scientist or the Investment Center of the Israeli Ministry of Industry and Commerce, the Israeli Antitrust Authority or the Israel Securities
Authority, or other person alleging the failure to comply with any statute, law, ordinance, rule, regulation, order or decree of any governmental
entity applicable to the Company and/or Subsidiary, or any of their respective businesses or operations;

 

4.25. Any
claim or demand made by purchasers, holders, lessors or other users of products of the Company, for damages, losses or personal injuries
related to such products;

 

    5

     

    

 

4.26. Any
claim or demand made in connection with any preparation or formulation of work plans, including pricing, marketing, distribution, instructions
to employees, customers and suppliers, and collaboration with competitors;

 

4.27. Any
acts in regard of invasion of privacy, participation and/or non-participation at Board meetings and/or voting and/or abstention from voting
at Board meetings, approval of corporate actions, claims of failure to exercise business judgment;

 

4.28. Claims
of failure to exercise business judgment and a reasonable level of proficiency, expertise and care in regard of the Company’s business;

 

4.29. Violations
of laws requiring the Company to obtain regulatory and governmental licenses, permits and authorizations in any jurisdiction;

 

4.30. Decisions
and/or actions relating to environmental compliance, including pollution, contamination and hazardous materials;

 

4.31. Granting
of liens on Company assets and granting guarantees on behalf of the Company;

 

4.32. Claims
in connection with publishing or providing any information, including any filings with governmental authorities in the U.S., Israel and
elsewhere, on behalf of the Company, in the circumstances required under applicable laws;

 

4.33. Claims
in connection with the preparation, approval or providing of any annual or quarterly financial statements, profit and loss statements,
balance sheets and similar financial information or forecasts;

 

4.34. Any
of the forgoing actions or decisions relating or otherwise applicable to any Subsidiary or Affiliate of the Company; and

 

4.35. Any
claim or demand, not covered by any of the categories of events described above, which, pursuant to any applicable law, a director or
officer of the Company may be held liable to any government or agency thereof, or any person or entity, in connection with actions taken
by such director or officer in such capacity.

 

		5.	Expenses; Indemnification Procedure. The Company shall advance Indemnitee all expenses incurred
by Indemnitee in connection with a Claim on the date on which such amounts are first payable (“Time of Indebtedness”),
and with respect to items mentioned in Section 1(ii) above, even prior to a court decision, but has no duty to advance payments in less
than twenty (20) days (but in any event not later than thirty (30) days) following delivery of a written request therefor by Indemnitee
to the Company. Advances given to cover legal expenses in criminal proceedings will be repaid by Indemnitee to the Company, if such proceedings
are concluded in such manner that would not have entitled the Indemnitee to indemnification under Section ‎1 above. Additionally,
the Company shall make available to Indemnitee any securities and/or guarantees which Indemnitee will be required to provide in the framework
of any action or proceeding and/or according to any interim decision, including arbitration proceedings, and including with respect to
the exchange of any attachments imposed on Indemnitee’s assets.

 

    6

     

    

 

		6.	Notification and Defense of Claim. If any Claim is brought against Indemnitee in respect of which
indemnity may be sought under this Agreement:

 

6.1. The
Indemnitee shall promptly notify the Company of any legal proceedings initiated and of all possible or threatened legal proceedings without
delay following first becoming aware thereof, and the Indemnitee shall deliver to the Company, or to such person as it shall advise, without
delay all documents received in connection with these proceedings. Similarly, the Indemnitee must advise the Company on an ongoing and
current basis concerning all events which the Indemnitee suspects may give rise to the initiation of legal proceedings against the Indemnitee.
Notice to the Company shall be directed to the Chief Executive Officer with a copy to the General Counsel and the Chief Financial Officer
of the Company as per Section 19 hereof, or if the Indemnitee is then the Chief Executive Officer of the Company, such notice shall be
directed to the Chairman of the Board and the other addressees.

 

6.2. The
Company will be entitled to participate therein at its own expense or to assume the defense thereof and to employ counsel reasonably satisfactory
to Indemnitee. Indemnitee shall have the right to employ its own counsel in connection with any such Claim and to participate in the defense
thereof, but the fees and expenses of such counsel shall be at the expense of Indemnitee unless: (i) the Company shall not have assumed
the defense of the Claim, or (ii) the named parties to any such action (including any impleaded parties) include both Indemnitee and the
Company, and Indemnitee shall have reasonably concluded that joint representation is inappropriate under applicable standards of professional
conduct due to a conflict of interest between Indemnitee and the Company, in either of which events reasonable fees and expenses of such
counsel to Indemnitee shall be borne by the Company. However, in no event will the Company be obligated to pay the fees or expenses of
more than one firm of attorneys representing Indemnitee in connection with any one Claim or separate but substantially similar or related
Claims in the same jurisdiction arising out of the same general allegations or circumstances. For the avoidance of doubt, in the case
of criminal proceedings the Company and/or the attorneys as aforesaid will not have the right to plead guilty in Indemnitee’s name
or to agree to a plea-bargain in his name without his prior written consent. Furthermore, in a civil proceeding (whether before a court
or as a part of a compromise arrangement), the Company and/or its attorneys will not have the right to admit to any occurrences that are
not indemnifiable pursuant to this Agreement and/or pursuant to law, without Indemnitee’s prior written consent. However, the aforesaid
will not prevent the Company and/or its attorneys as aforesaid, with the approval of the Company, to come to a financial arrangement with
a plaintiff in a civil proceeding without Indemnitee’s consent so long as such arrangement will not be an admittance of an occurrence
not fully indemnifiable pursuant to this Agreement and/or pursuant to law and further provided that any such settlement or arrangement
does not impose on Indemnitee any liability or limitation.

 

6.3. The
Company shall not be liable to indemnify Indemnitee for any amounts paid in settlement of any Claim effected without the Company’s written
consent. Indemnitee shall give the Company such information and cooperation as may be required.

 

    7

     

    

 

6.4. The
Indemnitee will fully cooperate with the Company and/or any attorney as aforesaid in every reasonable way as may be required within the
context of their conduct of such legal proceedings, including but not limited to the execution of power(s) of attorney and other documents,
provided that the Company shall cover all costs incidental thereto such that the Indemnitee will not be required to pay the same or to
finance the same himself.

 

		7.	Subrogation. In the event of payment under this Agreement from Company to Indemnitee, the Company
shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee, who shall execute all documents reasonably
required and shall do everything that may be reasonably necessary to secure such rights, including the execution of such documents necessary
to enable the Company effectively to bring suit to enforce such rights.

 

		8.	Primacy of Indemnification. The Company hereby acknowledges that Indemnitee has or may have certain
rights to indemnification, advancement of expenses and/or insurance provided by the Indemnitee or by the party or parties who appointed
the Indemnitee and certain of such party’s affiliates (collectively, the “Appointing Party”). The Company hereby agrees,
with respect to Indemnitee’s right to indemnification pursuant hereto: (i) that the Company is the indemnitor of first resort (i.e., its
obligations to Indemnitee are primary and any obligation of the Appointing Party or its (or the Indemnitee’s) insurer to advance expenses
or to provide indemnification for the same expenses or liabilities incurred by Indemnitee are secondary), (ii) that, subject to the provisions
hereof, the Company shall be required to advance the full amount of expenses incurred by Indemnitee and indemnifiable hereunder and shall
be liable for the full amount of all expenses, judgments, penalties, fines and amounts paid in settlement to the extent legally permitted
and as required by the Company’s Articles Association (or any agreement between the Company and Indemnitee) all subject to the provisions
hereof, without regard to any rights Indemnitee may have against the Appointing Party or its (or the Indemnitee’s) insurer, and, (iii)
that the Company irrevocably waives, relinquishes and releases the Appointing Party or its (or the Indemnitee’s) insurer from any and
all claims against the Appointing Party or its (or the Indemnitee’s) insurer for contribution, subrogation or any other recovery of any
kind in respect thereof. The Company further agrees that no advancement or payment by the Appointing Party or its (or the Indemnitee’s)
insurer on behalf of an Indemnitee with respect to any claim for which Indemnitee has sought indemnification from the Company shall affect
the foregoing and the Appointing Party or its (or the Indemnitee’s) insurer shall have a right of contribution and/or be subrogated to
the extent of such advancement or payment to all of the rights of recovery of Indemnitee against the Company. The Company and the Indemnitee
agree that the Appointing Party or its (or the Indemnitee’s) insurer are express third party beneficiaries of the terms hereof.

 

		9.	Partial Indemnification. If Indemnitee is entitled under any provision of this Agreement to indemnification
by the Company for some or a portion of the expenses actually or reasonably incurred by Indemnitee in connection with a Claim or Claims,
but not, however, for the total amount thereof, the Company shall nevertheless indemnify Indemnitee for the portion of such expenses to
which Indemnitee is entitled.

 

		10.	Other Indemnification. Except to the extent provided in Section 8 above, the Company will not indemnify
Indemnitee for any liability with respect to which Indemnitee has received payment by virtue of an insurance policy or other indemnification
agreement, other than for amounts, which are in excess of the amount paid to Indemnitee pursuant to such policy or agreement and other
than a deductible payable by the Indemnitee under an insurance policy or indemnification agreement.

 

    8

     

    

 

		11.	Collection from a Third Party. The Company will be entitled to any amount collected from a third
party in connection with a Claim or Claims actually indemnified hereunder by the Company.

 

		12.	Non-Exclusivity. The rights of the Indemnitee hereunder shall not be deemed exclusive of any other
rights he may have under the Company’s Articles of Association or applicable law or otherwise, and to the extent that during the
indemnification period hereunder the rights of the then existing directors and officers are more favorable to such directors or officers
than the rights currently provided thereunder or under this Agreement to Indemnitee, Indemnitee shall be entitled to the full benefits
of such more favorable rights.

 

		13.	Exemption. The Company hereby exempts Indemnitee, to the fullest extent permitted by law, from
any liability, or any part of liability, for damages caused as a result of a breach of his duty of care to the Company, provided that
in no event shall he be exempt with respect to any actions listed in Section ‎3.2 above.

 

		14.	Post Factum Indemnification. It is hereby clarified that nothing in here shall limit the Company’s
right to indemnify the Indemnitee post factum, for any and all amounts or events, without limitation.

 

		15.	Severability. Each of the provisions of this Agreement is a separate and distinct agreement and
independent of the others, so that if any provision hereof shall be held to be invalid or unenforceable for any reason, such invalidity
or unenforceability shall not affect the validity or enforceability of the other provisions hereof. If such invalid or unenforceable undertaking
may be modified or amended so as to be valid and enforceable as a matter of law, such undertaking will be deemed to have been modified
or amended, and any competent court or arbitrator are hereby authorized to modify or amend such undertaking, so as to be valid and enforceable
to the maximum extent permitted by law.

 

		16.	Termination of Services. For the avoidance of doubt, the Company will indemnify Indemnitee even
if at the relevant Time of Indebtedness Indemnitee is no longer a director or officer of the Company or of a Subsidiary or a director,
officer and/or board observer of an Affiliate, as applicable, provided, that the obligations are in respect of actions taken by the Indemnitee
while serving as a director, officer and/or board observer, as aforesaid, and in such capacity.

 

		17.	Attorneys’ Fees. In the event of any litigation or other action or proceeding to enforce
or interpret this Agreement, the prevailing party as determined by the court shall be entitled to an award of its reasonable attorneys’
fees and other costs, in addition to such relief as may be awarded by a court or other tribunal.

 

		18.	Further Assurances. The parties will do, execute and deliver, or will cause to be done, executed
and delivered, all such further acts, documents and things as may be reasonably required for the purpose of giving effect to this Agreement
and the transactions contemplated hereby. Notwithstanding anything to the contrary, if for the validation of any of the undertakings in
this Agreement any act, resolution, approval or other procedure is required, the Company undertakes to cause them to be done or adopted
in a manner which will enable the Company to fulfill all its undertakings as aforesaid.

 

    9

     

    

 

		19.	Notice. All notices, requests, demands and other communications under this Agreement shall be in
writing and shall be deemed duly given (i) if delivered by hand or by fax or other means of electronic communication and receipted for
by the party addressee, on the date of such receipt, or (ii) if mailed by certified or registered mail with postage prepaid, on the third
business day after the date postmarked.

 

		20.	Entire Agreement; Amendments. This Agreement constitutes the entire agreement between the parties
with respect to its subject matter, and supersedes and cancels all prior agreements, proposals, representations and communications between
the parties regarding the subject matter hereof. No amendment, modification, termination or cancellation of this Agreement shall be effective
unless it is in writing and signed by the parties hereto.

 

		21.	Binding Effect; No Assignment. This Agreement shall be binding upon Indemnitee and the Company,
their successors and assignees, and shall inure to the benefit of Indemnitee, his heirs, personal representatives and assignees and to
the benefit of the Company, its successors and assignees. Indemnitee shall not assign or otherwise transfer his rights under this Agreement
and any attempt to assign or transfer such rights shall be deemed null and void.

 

		22.	Governing Law; Jurisdiction. This Agreement shall be interpreted and enforced in accordance with
the laws of the State of Israel, without regard to their rules of conflict of laws, and any dispute arising from or in connection with
this Agreement is hereby submitted to the sole and exclusive jurisdiction of the competent courts in Tel Aviv, Israel.

 

		23.	Construction. The undertakings of the parties pursuant to this Agreement shall be widely construed
and, in a manner, designated to give them effect, to the fullest extent permissible under law. In the event of any contradiction between
the provisions of this Agreement and any provision of law that is not dispositive or which cannot be amended, the provision of law shall
prevail but the same shall not impair or derogate from the validity of the other provisions hereunder.

 

		24.	Counterpart Signatures. This Agreement may be executed in counterparts, both of which when taken
together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and
delivered to the other party, it being understood that two parties need not sign the same counterpart. In the event that any signature
is delivered by facsimile or PDF transmission, such signature shall create a valid and binding obligation of the party executing (or on
whose behalf such signature is executed) the same with the same force and effect as if such facsimile or PDF signature page were an original
thereof.

 

    10

     

    

 

IN WITNESS WHEREOF, the parties hereto have executed
this Agreement as of the day and year first above written.

 

	
    Indemnitee
	 	Jeffs’ Brands Ltd
	 	 	 	 
	
    /s/ Ronen
    Zalayet
	 	By:	/s/ Viki Hakmon
	Name: Ronen Zalayet	 	Name: 	Viki Hakmon
	Title: Chief Financial Officer	 	Title:	Chief Executive Officer

 

    11

     

    

 

Schedule to Exhibit 10.1

 

The following directors and
executive officers of Jeffs’ Brands Ltd (the “Company”) are parties to Indemnification Agreements with the Company
which are substantially identical in all material respects to the representative Indemnification Agreement filed herewith and are dated
as of the respective dates listed below. The other Indemnification Agreements are omitted pursuant to Instruction 2 to Item 601 of Regulation
S-K.

 

	Name of Signatory	 	Date
	
    Viki Hakmon

    Chief Executive Officer and Director
	 	November 20, 2022
	 	 	 
	
    Ronen Zalayet

    Chief Financial Officer
	 	November 20, 2022
	 	 	 
	
    Naor Bergman

    Chief Operating Officer
	 	November 20, 2022
	 	 	 
	
    Oz Adler

    Chairman of the Board of Directors
	 	November 20, 2022
	 	 	 
	
    Eliyahu Yoresh

    Director
	 	November 20, 2022
	 	 	 
	
    Liron Carmel

    Director
	 	November 20, 2022
	 	 	 
	
    Tali Dinar

    Director
	 	November 20, 2022
	 	 	 
	
    Moshe Revach

    Director
	 	November 20, 2022
	 	 	 
	
    Amitay Weiss

    Director
	 	November 20, 2022
	 	 	 
	
    Tomer Etzyoni

    Director
	 	November 20, 2022
	 	 	 
	
    Asaf Itzhaik

    Director
	 	November 20, 2022

 

 

12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}]]